Somalogic (SLGC) Reports Prelim FY22 Revenue of $93M-$98M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
January 9, 2023 9:00 AM ESTBOULDER, Colo., Jan. 09, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that preliminary, unaudited revenue for the full year 2022 is expected to be at the high end of its guidance range of $93 to $98 million, reflecting approximately 20% year-over-year revenue growth.
In addition, SomaLogic is pleased to announce several organizational and strategic updates:
Newly signed agreement with Group 42 Healthcare (G42) to use SomaLogic as its sole proteomics provider for a world-class multi-omic research and healthcare initiative, expanding the Companys reach in international markets. The agreement spans... More